| Bioactivity | AVX001 is an inhibitor of phospholipase A2 (cPLA2α) that can be used in the research of psoriasis[1]. |
| CAS | 300553-18-8 |
| Formula | C21H29F3OS |
| Molar Mass | 386.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. S H Omland, et al. A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1161-1167. |